# Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

> clinical trial · VERIFIED · 2025-05-09

Status: COMPLETED · Sponsor: Neurotech Pharmaceuticals · Condition: MacTel (Macular Telangiectasia) Type 2

- Company: Neurotech Pharmaceuticals
- Sector: ophthalmology
- Primary source: https://clinicaltrials.gov/study/NCT03071965

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.